TW286273B - - Google Patents

Info

Publication number
TW286273B
TW286273B TW083105534A TW83105534A TW286273B TW 286273 B TW286273 B TW 286273B TW 083105534 A TW083105534 A TW 083105534A TW 83105534 A TW83105534 A TW 83105534A TW 286273 B TW286273 B TW 286273B
Authority
TW
Taiwan
Prior art keywords
pct
core member
support means
sec
delivery
Prior art date
Application number
TW083105534A
Other languages
English (en)
Chinese (zh)
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of TW286273B publication Critical patent/TW286273B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Paper (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
  • Details Of Garments (AREA)
TW083105534A 1993-06-17 1994-06-15 TW286273B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Publications (1)

Publication Number Publication Date
TW286273B true TW286273B (enExample) 1996-09-21

Family

ID=8538154

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105534A TW286273B (enExample) 1993-06-17 1994-06-15

Country Status (24)

Country Link
US (1) US5694947A (enExample)
EP (1) EP0703802B1 (enExample)
JP (1) JP3803714B2 (enExample)
KR (1) KR100312764B1 (enExample)
CN (1) CN1126574C (enExample)
AT (1) ATE177657T1 (enExample)
AU (1) AU674758B2 (enExample)
BR (1) BR9407118A (enExample)
CZ (1) CZ284989B6 (enExample)
DE (1) DE69417232T2 (enExample)
DK (1) DK0703802T3 (enExample)
EE (1) EE03202B1 (enExample)
ES (1) ES2130423T3 (enExample)
FI (1) FI95768C (enExample)
GR (1) GR3030565T3 (enExample)
HU (1) HU217950B (enExample)
LT (1) LT3455B (enExample)
LV (1) LV12452B (enExample)
MY (1) MY113965A (enExample)
NO (1) NO311498B1 (enExample)
PL (1) PL176664B1 (enExample)
RU (1) RU2121824C1 (enExample)
TW (1) TW286273B (enExample)
WO (1) WO1995000199A1 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
DE69929055T2 (de) * 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
CN1822815B (zh) * 2003-07-10 2012-04-11 沃纳奇尔科特(爱尔兰)有限公司 阴道内药物传递装置
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP1906987B1 (en) 2005-07-19 2011-01-19 The Population Council, Inc. Methods and compositions for emergency contraception using endothelin receptor antagonists
BRPI0709344A2 (pt) * 2006-03-20 2011-07-12 Duramed Pharmaceuticals Inc anel intravaginal comprimido flexìvel, seu uso e processo de preparação, método de fornecer um agente ativo, kit terapêutico e produto
AU2007324588B2 (en) * 2006-11-20 2012-09-13 Intervet International B.V. Helically-shaped drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
CN101977651A (zh) * 2008-01-25 2011-02-16 犹他大学研究基金会 线性级释放聚合物
EP2249757B1 (en) 2008-02-04 2017-08-09 Ferring B.V. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI20095563A7 (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
CN104887388B (zh) 2009-06-03 2018-01-09 弗赛特影像5股份有限公司 前段药物输送
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2749286B1 (en) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
EP2755615B1 (en) 2011-09-14 2022-04-06 Forsight Vision5, Inc. Ocular insert apparatus
CN103007427B (zh) * 2011-09-21 2016-01-20 上海市计划生育科学研究所 缓控释宫内释药器及其制备方法
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2641602A1 (en) 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20150051234A (ko) 2012-09-03 2015-05-11 에쏘세아 파르밍 에쎄.아. 수생 생물종의 배향 및／또는 억제를 위한 저장조 케이지 침지 시스템
SI2911623T1 (sl) 2012-10-26 2019-12-31 Forsight Vision5, Inc. Oftalmični sistem za podaljšano sproščanje zdravila v oko
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2015014199A (es) 2013-04-10 2016-06-21 Preglem Sa Moduladores del receptor de progesterona para usarse en la terapia de fibromas uterinos.
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA3208334A1 (en) * 2014-04-01 2015-10-08 Poly-Med, Inc. Contraceptive and related device
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2728504T3 (es) 2014-06-26 2019-10-25 Taris Biomedical Llc Dispositivos de administración de fármacos por vía intravesical y métodos que comprenden sistemas matriciales polímero-fármaco elásticos
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN110403565B (zh) * 2018-04-27 2022-02-11 西安交通大学医学院第一附属医院 一种胶囊内窥镜磁与麦芒仿生双驱动装置
CN109771124A (zh) * 2019-01-31 2019-05-21 山东省药学科学院 一种具有形状记忆功能的子宫托
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1264731A (en) * 1917-03-19 1918-04-30 Carl Willers Pneumatic die-cushion.
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3911911A (en) * 1969-06-16 1975-10-14 Reese Hospital Michael Anti-fertility device
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE2616064A1 (de) * 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ATE21331T1 (de) * 1981-12-30 1986-08-15 Population Council Inc Verfahren zur herstellung von intrauterinen vorrichtungen.
JPS5919151U (ja) * 1982-07-28 1984-02-06 ニツポ−株式会社 痔疾治療器
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4822161A (en) * 1988-01-19 1989-04-18 Jimmy Michael F Illuminating spectacle apparatus
JPH02185264A (ja) * 1988-12-16 1990-07-19 Ferring Bv 膀胱内又は尿管へ薬を送り込む方法及び装置
KR100236355B1 (ko) * 1990-03-16 2000-01-15 이데이 노부유끼 와이프 패턴의 발생장치
JP3186105B2 (ja) * 1991-07-26 2001-07-11 日本電気株式会社 半導体装置のテストモード設定・解除回路
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
DE69417232T2 (de) 1999-11-04
JP3803714B2 (ja) 2006-08-02
JPH08511240A (ja) 1996-11-26
FI932789L (fi) 1994-12-18
CN1125403A (zh) 1996-06-26
AU674758B2 (en) 1997-01-09
RU2121824C1 (ru) 1998-11-20
LTIP1957A (en) 1995-01-31
NO955029L (no) 1995-12-12
GR3030565T3 (en) 1999-10-29
ATE177657T1 (de) 1999-04-15
FI95768C (fi) 1996-03-25
EP0703802A1 (en) 1996-04-03
AU6848194A (en) 1995-01-17
FI95768B (fi) 1995-12-15
LT3455B (en) 1995-10-25
PL312193A1 (en) 1996-04-01
HU217950B (hu) 2000-05-28
BR9407118A (pt) 1996-09-03
FI932789A0 (fi) 1993-06-17
KR100312764B1 (ko) 2002-11-23
LV12452A (lv) 2000-04-20
US5694947A (en) 1997-12-09
EP0703802B1 (en) 1999-03-17
PL176664B1 (pl) 1999-07-30
HU9503290D0 (en) 1996-01-29
NO955029D0 (no) 1995-12-12
MY113965A (en) 2002-07-31
CN1126574C (zh) 2003-11-05
EE03202B1 (et) 1999-08-16
CZ320895A3 (en) 1996-07-17
CZ284989B6 (cs) 1999-04-14
NO311498B1 (no) 2001-12-03
LV12452B (en) 2000-09-20
DE69417232D1 (de) 1999-04-22
ES2130423T3 (es) 1999-07-01
DK0703802T3 (da) 1999-10-11
HUT74548A (en) 1997-01-28
KR960703024A (ko) 1996-06-19
WO1995000199A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
TW286273B (enExample)
GR3024468T3 (en) Inhalation powder containing antistatic agent.
HUT71683A (en) Microparticle preparations made from biodegradable copolymers
GB9203037D0 (en) Contrast agents
HU9500631D0 (en) Sealing member
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
GR3025868T3 (en) Support catalyst and use of same.
HU9501057D0 (en) Gestagenically active 19,11-bridged 4-estrenes
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
EP0647654A3 (enExample)
CA2165282A1 (en) Intravaginal delivery system
WO1996024378A3 (en) Delivery of exogenous compounds
EP0634168A4 (enExample)
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
MX9701031A (es) Utilizacion de la selegilina para el tratamiento de enfermedades epilepticas.
ES2141044A1 (es) Terapia con oxibutinina.
GB9315411D0 (en) Active agent delivery
FR2696066B1 (fr) Procédé pour transmettre des messages, et unité fonctionnelle et installation s'y rapportant.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees